£669k
+26%vs Feb 2024Active11218653Private limited companyHigh Wycombe
Q2 PHARMA LIMITED
Significant control: Q2 Group International Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Q2 Pharma Limited sell?
Registered activity: Dispensing chemist in specialised stores (SIC 47730). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
Q2 PHARMA LIMITED is an active private limited company (company number 11218653) incorporated on 21 February 2018, registered in High Wycombe. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest small accounts cover the period ending 28 February 2025, showing net assets of £669k and cash of £417k, with 18 employees on average. Net assets rose 26% on the prior period (£532k).
Peer position · net assets
By net assets it sits in the top quarter of 535 comparable companies in Other (median £27k, upper quartile £220k).
02
Ownership and control
- Q2 Group International Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Mohammad Tahir Comran
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 21 February 20188 yrs ago
- Next accounts due
- 28 November 2026in 36 days
- Confirmation statement due
- 7 March 2027in 135 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£417k
+78%vs Feb 2024Not reported
18
+38%vs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £669k | £417k | £635k | — | — | — | 18 |
| 28 February 2024 | £532k | £234k | £477k | — | — | — | 13 |
Cash per employee£23kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £668,742 at 28 February 2025
- Net assets up 10% or more on the prior period+25.6% vs prior period
- Cash at bank of £50,000 or moreCash £417,466
- Incorporated five or more years agoIncorporated 21 February 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 135 days
- Next accounts duein 36 days
- Accounts period endNet assets £669k · small accounts
- Accounts period endNet assets £532k · small accounts
- Incorporated
08
Similar companies in the UK
- ALEXANDRU SUHAROSCHI LTDPlymouth · inc. Feb 2018
- LOCUM SOLUTIONS SOUTHWEST LIMITEDBude · inc. Feb 2018
- GULPEPPER LTDBodmin · inc. Feb 2018
- BELL WALK HEALTHCARE LTDGloucester · inc. Jan 2018
- BEMR INVESTMENTS LTDHornsea · inc. Apr 2018
- D & M GOMPELS LIMITEDMelksham · inc. May 2018
All companies incorporated on 21 February 2018 · in Feb 2018.
09
Reminders for Q2 PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.